« Predictors of survival in severe, early onset COPD. | Main | Iran Says Nuclear Freeze Won't Last Long »
November 30, 2004
Study: Drug helps sickest cancer patients
Topics: Clinical PharmacologyPosted on Mon, Nov. 29, 2004, Associated Press, Reported in Mercurynews.com The South San Francisco-based biotechnology titan made the
announcement ahead of a major conference for cancer researchers and
doctors scheduled for January, when the company said it would release
more detailed results from a large-scale human experiment using Avastin
in combination with a chemotherapy treatment. "This study provides additional evidence that adding Avastin to
chemotherapy results in a significant survival benefit for patients
with either untreated or relapsed metastatic colorectal cancer," said
Dr. Hal Barron, Genentech's chief medical officer. The company said patients receiving Avastin and chemotherapy
survived, on average, for 12 months compared to 10 months for patients
receiving chemotherapy only. Read More...
SAN FRANCISCO - Genentech
Inc. said Monday its novel colon cancer-fighting drug Avastin helped
some of the sickest patients stay alive two months longer than
expected, giving the drug an additional boost on its way to blockbuster
status.
Posted by Hyscience at November 30, 2004 12:47 AM
Articles Related to Clinical Pharmacology:
- Study: Drug helps sickest cancer patients - Nov 30, 2004
